In one subtype of DLBCL, of activated B-cell origin (ABC), NF-κB signaling is constitutively activated due to mutations of important B-cell receptor (BCR) signaling genes [11]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.